Hospital
Xiangya Hospital of Central South University中南大学湘雅医院
At a glance
Published values only, each read from the record this page is built on. The listings behind them are in the section below.
-
Fudan University hospital rankings A++++ General list, 2023
-
National key clinical specialties 25 at evidence level A or B
-
Research platforms 1 national clinical research centres and state key laboratories
-
Published research 7 PubMed records we hold for this hospital (the newest twenty per hospital)
-
Registered studies 22 records we hold for this hospital, as registered
Rankings & accreditation
These listings are published by the bodies that run them, not by this site. Every line carries the year it was published and a link to its source; this is not a paid or promoted listing.
Fudan University hospital rankings
| Item | Rank / tier | Year | Caliber | Source |
|---|---|---|---|---|
| General list | A++++ | 2023 | Tier only; hospitals in the same tier are not ordered against each other | https://rank.cn-healthcare.com/fudan/national-general |
Fudan specialty reputation ranking
| Item | Rank / tier | Year | Caliber | Source |
|---|---|---|---|---|
| Otorhinolaryngology 耳鼻喉科 | #10 | 2023 | Place in the specialty reputation ranking | https://www.fdygs.com/news2023-1.aspx |
National key clinical specialties
| Specialty | Batch | Evidence | Source |
|---|---|---|---|
| Specialist Nursing 专科护理 | 2010 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Integrated TCM and Western Medicine (encephalology) 中西医结合脑病科 | 2011 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Key Laboratory of Tumour Proteomics (Ministry of Health) 卫生部肿瘤蛋白质组学重点实验室 | 2013-2014 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Stomatology (oral and maxillofacial surgery) 口腔(口腔颌面外科专业) | 2011 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Respiratory Medicine 呼吸内科 | 2012 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Cardiology 心血管内科 | 2011 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Emergency Medicine 急诊医学科 | 2013-2014 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Infectious Diseases 感染病科 | 2013-2014 | Level B | https://www.xiangya.com.cn/zdzk.html |
| General Surgery 普通外科 | 2012 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Urology 泌尿外科 | 2012 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Burns and Plastic Surgery 烧伤外科 | 2012 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Pathology 病理学 | 2010 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Dermatology 皮肤科 | 2012 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Neurology 神经内科 | 2012 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Neurosurgery 神经外科 | 2011 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Geriatrics 老年病科 | 2013-2014 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Otorhinolaryngology 耳鼻咽喉科 | 2011 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Nephrology 肾病科 | 2012 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Medical Oncology 肿瘤科 | 2013-2014 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Hematology 血液内科 | 2011 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Orthopedics 运动医学科 | 2013-2014 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Critical Care Medicine 重症医学科 | 2010 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Rheumatology and Immunology 风湿免疫科 | 2013-2014 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Orthopedics 骨科 | 2010 | Level B | https://www.xiangya.com.cn/zdzk.html |
| Anesthesiology 麻醉学科 | 2010 | Level B | https://www.xiangya.com.cn/zdzk.html |
25 specialty rows, each carrying its own evidence level.
Each row carries its own evidence level and its own source. Level definitions are on the methodology page.
Values written in Chinese are quoted as published by the source.
National clinical research platforms
| Item | Rank / tier | Year | Caliber | Source |
|---|---|---|---|---|
| National Clinical Research Center for Geriatric Diseases 国家老年疾病临床医学研究中心 | National clinical research centre | 2016 | Platform hosted by this hospital | https://www.most.gov.cn/tztg/201602/t20160219_124165.html |
Administrative grade
| Item | Rank / tier | Year | Caliber | Source |
|---|---|---|---|---|
| Grade as published Tier 3, class A 三级甲等 | Tier 3, class A | Batch 2, 2024-01-30 第二批 2024-01-30 | An administrative designation, not a ranking; the date is the list's own publication date, not the year the grade was awarded | The source of this record, at the foot of this page |
Conditions treated here
Conditions this site files under the specialties above. It is a record of the listings, not a recommendation.
For international patients
A line appears here only where we hold a record for it. A line that is missing has not been verified - ask us and we will put the question to the hospital.
Hospital details
- Chinese name
- 中南大学湘雅医院
- English name
- Xiangya Hospital of Central South University
- Grade
- Tier 3, class A 三级甲等
- Grade list as published
- Batch 2, 2024-01-30 第二批 2024-01-30
Values written in Chinese are quoted as published by the source.
The grade list reference is the date or review batch the official list was published under; it is quoted in the source's language.
Also known as
- Xiangya Hospital Central South University
Evidence for this condition
Selected using official public data sources
-
Colorectal cancer
Fudan specialty reputation ranking 2023
- General Surgery nominated https://www.fdygs.com/news2023-1.aspx
National key clinical specialty
- General Surgery (level B) https://www.xiangya.com.cn/zdzk.html
Also ranked: Otorhinolaryngology #10, Urology nominated, Medical Oncology nominated in the Fudan list.
-
Lung cancer
Fudan specialty reputation ranking 2023
- Respiratory Medicine nominated https://www.fdygs.com/news2023-1.aspx
National key clinical specialty
- Respiratory Medicine (level B) https://www.xiangya.com.cn/zdzk.html
Published research
- Internet of Things-Enabled Pulmonary Rehabilitation for Advanced Lung Cancer Patients Receiving Chemotherapy: A Qualitative Study of Healthcare Professional and Patient Perspectives. Journal of multidisciplinary healthcare, 2026
- Trastuzumab Deruxtecan in Patients From China With Pretreated HER2-Mutant Non-Small Cell Lung Cancer: Final Analysis of the Phase 2, Single-Arm DESTINY-Lung05 Trial. Clinical lung cancer, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Otorhinolaryngology #10, General Surgery nominated, Urology nominated in the Fudan list.
-
Liver cancer
Published research
- [Corrigendum] CLEC4M overexpression inhibits progression and is associated with a favorable prognosis in hepatocellular carcinoma. Molecular medicine reports, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Otorhinolaryngology #10, General Surgery nominated, Urology nominated in the Fudan list.
-
Stomach cancer
Published research
- Response to Comments on “Prognostic Significance of Pretreatment [¹⁸F]ALF-NOTA-FAPI-04 PET/CT in Patients With Recurrent Gastric Cancer Undergoing Combined PD-1 Inhibitor and Chemotherapy”. Korean journal of radiology, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Otorhinolaryngology #10, General Surgery nominated, Urology nominated in the Fudan list.
-
Prostate cancer
Fudan specialty reputation ranking 2023
- Urology nominated https://www.fdygs.com/news2023-1.aspx
National key clinical specialty
- Urology (level B) https://www.xiangya.com.cn/zdzk.html
Also ranked: Otorhinolaryngology #10, General Surgery nominated, Medical Oncology nominated in the Fudan list.
-
Nasopharyngeal carcinoma
Fudan specialty reputation ranking 2023
- Otorhinolaryngology #10 https://www.fdygs.com/news2023-1.aspx
National key clinical specialty
- Otorhinolaryngology (level B) https://www.xiangya.com.cn/zdzk.html
Published research
- A novel surgical T staging system for recurrent nasopharyngeal carcinoma: advancing prognostic accuracy and clinical applicability. Journal of neurosurgery, 2026
- TQB2618 plus Penpulimab, Alone or in Combination with Chemotherapy, for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter, Two-Cohort, Phase II Trial. Clinical cancer research : an official journal of the American Association for Cancer Research, 2026
1 more published study
PubMed indexes 3 papers on this condition that name this hospital.
Also ranked: General Surgery nominated, Urology nominated, Medical Oncology nominated in the Fudan list.
-
Bladder cancer
Fudan specialty reputation ranking 2023
- Urology nominated https://www.fdygs.com/news2023-1.aspx
National key clinical specialty
- Urology (level B) https://www.xiangya.com.cn/zdzk.html
Also ranked: Otorhinolaryngology #10, General Surgery nominated, Medical Oncology nominated in the Fudan list.
-
Pancreatic cancer
Fudan specialty reputation ranking 2023
- General Surgery nominated https://www.fdygs.com/news2023-1.aspx
- Medical Oncology nominated https://www.fdygs.com/news2023-1.aspx
National key clinical specialty
- General Surgery (level B) https://www.xiangya.com.cn/zdzk.html
- Medical Oncology (level B) https://www.xiangya.com.cn/zdzk.html
Also ranked: Otorhinolaryngology #10, Urology nominated, Respiratory Medicine nominated in the Fudan list.
-
Kidney cancer
Fudan specialty reputation ranking 2023
- Urology nominated https://www.fdygs.com/news2023-1.aspx
National key clinical specialty
- Urology (level B) https://www.xiangya.com.cn/zdzk.html
Also ranked: Otorhinolaryngology #10, General Surgery nominated, Medical Oncology nominated in the Fudan list.
-
Senile cataract
Fudan specialty reputation ranking 2023
- Ophthalmology nominated https://rank.cn-healthcare.com/fudan/specialty-reputation/year/2023/sid/4
Also ranked: Otorhinolaryngology #10, General Surgery nominated, Urology nominated in the Fudan list.
-
Non-Hodgkin lymphoma
National key clinical specialty
- Hematology (level B) https://www.xiangya.com.cn/zdzk.html
Also ranked: Otorhinolaryngology #10, General Surgery nominated, Urology nominated in the Fudan list.
-
Leukaemia
National key clinical specialty
- Hematology (level B) https://www.xiangya.com.cn/zdzk.html
Also ranked: Otorhinolaryngology #10, General Surgery nominated, Urology nominated in the Fudan list.
-
Brain tumour
National key clinical specialty
- Neurosurgery (level B) https://www.xiangya.com.cn/zdzk.html
Also ranked: Otorhinolaryngology #10, General Surgery nominated, Urology nominated in the Fudan list.
-
Hip and knee replacement
National key clinical specialty
- Orthopedics (level B) https://www.xiangya.com.cn/zdzk.html
- Orthopedics (level B) https://www.xiangya.com.cn/zdzk.html
Also ranked: Otorhinolaryngology #10, General Surgery nominated, Urology nominated in the Fudan list.
-
Bone and soft tissue sarcoma
Fudan specialty reputation ranking 2023
- Medical Oncology nominated https://www.fdygs.com/news2023-1.aspx
National key clinical specialty
- Medical Oncology (level B) https://www.xiangya.com.cn/zdzk.html
- Orthopedics (level B) https://www.xiangya.com.cn/zdzk.html
- Orthopedics (level B) https://www.xiangya.com.cn/zdzk.html
Also ranked: Otorhinolaryngology #10, General Surgery nominated, Urology nominated in the Fudan list.
Other hospitals in Changsha
Source & evidence
- Source URL
- https://rank.cn-healthcare.com/fudan/national-general
- Source scheme
- https
- Source type
- Third-party compilation
- Evidence level
- B - hospital self-statement or authoritative media
- Retrieved on
- 2026-09-24